The theory that glucagon-like peptide-1 (GLP-1) receptor agonists may have beneficial effects on the lungs gained support from recent analyses of patients with asthma, chronic lower respiratory diseases, and all types of respiratory diseases.
Recent studies found higher HbA1c levels in younger patients with diabetes compared to older ones, as well as differences in medication therapy by age.
One study found that personalized text messaging improved patients' self-management while another looked at the potential value of providing social comparisons to other patients' diabetes control.
Recent studies looked at stroke risk among patients with diabetes and the effects of hypertension treatment, acetaminophen use, gout, and obesity.
A few case reports suggested a link between SARS-CoV-2 and development of insulin-dependent diabetes, but recent analyses of type 1 diabetes incidence during the pandemic have shown mixed results.
Control of cholesterol levels among patients with type 2 diabetes commonly falls short of recommendations, according to two recent studies of contemporary practice in other countries.
A new study validated a score for predicting risk of heart failure in patients with type 2 diabetes, while another looked at historical trends in heart failure hospitalizations in U.S. diabetes patients.
Several recent studies have found evidence that outcomes from COVID-19 differ by the diabetes medications patients were taking before they got sick, including metformin being associated with better outcomes, but confounding by indication is likely,
Recent studies looked at aspects of pregnancy in women with pre-existing type 1 or 2 diabetes, including rates of adverse outcomes, useful biomarkers, and typical dietary patterns.
Experts gave advice on which diabetes drugs should be stopped in patients with COVID-19, and studies highlighted associations between the two diseases.